Aggregation of diverse cancer types in one family may be caused by shared genetic and/or environmental factors. Mutations in disease genes or exposure to potent environmental carcinogens may lead to malignant disease in a high proportion of cases regardless of the presence of co-factors. In other instances an interaction between an environmental agent and a normal genetic variant is needed to result in disease. This study was performed to examine possible aggregation of diverse cancer types in the families of testicular cancer patients.
Moss et al. (1985) and Swerdlow et al. (1987) have reported an increase in breast cancer in mothers and lung cancer in parents of testicular cancer patients respectively in case-control studies. Similarly, there have been reports that testicular cancer may be part of the Li-Fraumeni syndrome (Hartley et al., 1989 There have been theories of hormonal imbalance in the mothers of patients as a cause of testicular cancer (Henderson et al., 1979) . Cancer of the endometrium has been related to oestrogen excess (Olsson, 1990) . Although not firmly established, prostate cancer has similarly been linked to a relative androgen excess and breast cancer to disturbances both in the oestrogen and progesterone metabolism (Ross et al., 1988; Olsson, 1990 We were able to confirm 92% of the cancers reported by the Norwegian patients in first-degree relatives and 84% in the grandparents.
Standardised incidence ratios (SIRs) for first-degree relatives were calculated as observed number/expected number for all cancers combined and for specific cancer diagnoses (Table I) , Heimdal et al., 1996 .
Only first cancers occurring in the relatives were considered. The calculation of SIRs for specific cancer diagnoses were done in order to support or weaken previously published hypotheses of testicular cancer pathogenesis as detailed in the introduction. However, leukaemias were not tested because of the suspicion that the Cancer Registry in Norway is incomplete for these disease entities. Expected numbers of cancers were derived according to cancer incidence in the relevant Norwegian/Swedish population as described (Heimdal et al., 1996) . The calculations were done separately on the Norwegian and Swedish cohort before pooling the results. Ninety-five per cent confidence intervals (CIs) were calculated assuming a Poisson distribution of observed cases.
The Norwegian families were evaluated by one of the authors (KH) for the occurrence of known familial cancer syndromes according to previously published criteria (Moller P., 1993; Li et al., 1988; Vasen et al., 1991) . For these families, both confirmed and reported cancers have been included in the report.
Results
The first-degree relatives in the total material and of the Norwegian testicular cancer patients had 10% fewer cancers than expected (Table I ). This finding is of borderline statistical significance. In the relatives of the Swedish patients, who account for less than 20% of all cases, SIR was close to one. The SIR was lowest for fathers of cases. For the children, numbers were too small to draw any conclusions about non-testicular cancers.
When specific cancers were analysed in all cases a statistically significant excess of lung cancers (ICD 162) in mothers but not in other first-degree relatives was found (Table II Mothers, but not sisters, had a small excess of cancers of the endometrium (Table II) . Breast cancers were only slightly increased in mothers and not elevated in sisters (Table II) (Moller P., 1993) . In one of these families, the proband was the son of an unaffected mother and in two other families it was the father of the proband who belonged to the breast cancer family.
Similarly, four families were classified as breast ovarian cancer families. In these families one proband was the son of an unaffected mother while the remaining probands were sons of affected mothers. No family was compatible with the hereditary non-polyposis colon cancer (HNPCC) syndrome.
In the Norwegian cohort, 77/797 (9.6%) of the patients had bilateral and/or familial testicular cancer. We observed 22 non-testicular cancers in the first-degree relatives (sibs and parents) and 28 in the grandparents of these patients. By comparison, the first-degree relatives of the total Norwegian cohort had 250 cancers and the grandparents 267 cancers. Thus, 50/517 (9.7%) of the cancers in the relatives of the Norwegian testicular cancer patients occurred in the families of patients with bilateral and/or familial testicular cancer. The observed number of cancers is too small to draw any conclusions about specific types of cancer on clustering of cases in certain families, and no obvious pattern emerged (data not shown).
Discussion
In this study we found a decrease in total cancer incidence in the families of testicular cancer patients. This apparent decrease in incidence of major cancers may in part be caused by underreporting by the probands and our method of verification of cancers. We attempted to confirm the cancer diagnosis in relatives reported to have had cancer, but did not make attempts to check for cancer in those relatives reported to be free of the disease. The fact that the SIRs were even lower for grandparents than for first-degree relatives in the Norwegian cohort (data not shown) support this hypothesis of underreporting. Testicular cancer patients may be less likely to know of cancers in the grandparents than in their first-degree relatives. On the other hand, it may be that there is a deficit of factors predisposing to common (Kaldor et al., 1987; Fossa et al., 1990; Moller H. et al., 1993; Jacobsen et al., 1993; van-Leeuwen et al., 1993 (Newman et al., 1988; Claus et al., 1991; Iselius et al., 1991 Iselius et al., , 1992 . If we set the gene frequency to 1:200-1:300, the expected number of breast(-ovarian) families would be 3-5. Thus, on the basis of the present data, testicular cancer is not shown to be a clear component of this syndrome, although this possibility cannot be excluded.
One patient belonged to a Li-Fraumeni cancer family. Including the present case testicular germ cell tumours have now been reported in four and ovarian germ cell tumour in one Li-Fraumeni family (Hartley et al., 1989; Scott et al., 1993) . This raises the possibility that in rare cases gonadal germ cell tumours are part of this extremely rare cancer family syndrome. Molecular data from testicular germ cell tumours, however, do not seem to support this view since very few tumours have been shown to have TP53 mutations (Heimdal et al., 1993; Peng et al., 1993; Ye et al., 1993; Strohmeyer et al., 1993) .
In conclusion, there is no overall excess of cancer in relatives of testicular cancer patients, but some interesting imbalances in the incidence of some cancer types possibly related to hormonal imbalances in the parents of testicular cancer patients were observed. Neither sporadic unilateral nor familial and bilateral testicular cancer seem to be an obvious part of any of the known cancer family syndromes.
